Reincke M, Fleseriu M (2023) Cushing syndrome: A review. JAMA 330:170–181. https://doi.org/10.1001/jama.2023.11305

Article  CAS  PubMed  Google Scholar 

Gadelha M, Gatto F, Wildemberg LE, Fleseriu M (2023) Cushing’s syndrome. Lancet 402:2237–2252. https://doi.org/10.1016/S0140-6736(23)01961-X

Article  PubMed  Google Scholar 

Braun LT, Vogel F, Zopp S et al (2022) Whom should we screen for Cushing syndrome?? The endocrine society practice guideline recommendations 2008 revisited. J Clin Endocrinol Metab 107:e3723–e3730. https://doi.org/10.1210/clinem/dgac379

Article  PubMed  PubMed Central  Google Scholar 

Pivonello R, Isidori AM, De Martino MC et al (2016) Complications of cushing’s syndrome: state of the Art. Lancet Diabetes Endocrinol 4:611–629. https://doi.org/10.1016/S2213-8587(16)00086-3

Article  CAS  PubMed  Google Scholar 

Limumpornpetch P, Morgan AW, Tiganescu A et al (2022) The effect of endogenous Cushing syndrome on All-cause and Cause-specific mortality. J Clin Endocrinol Metab 107:2377–2388. https://doi.org/10.1210/clinem/dgac265

Article  PubMed  PubMed Central  Google Scholar 

Fleseriu M, Auchus R, Bancos I et al (2021) Consensus on diagnosis and management of cushing’s disease: a guideline update. Lancet Diabetes Endocrinol 9:847–875. https://doi.org/10.1016/S2213-8587(21)00235-7

Article  PubMed  PubMed Central  Google Scholar 

Nieman LK, Biller BMK, Findling JW et al (2008) The diagnosis of cushing’s syndrome: an endocrine society clinical practice guideline. J Clin Endocrinol Metab 93:1526–1540. https://doi.org/10.1210/jc.2008-0125

Article  CAS  PubMed  PubMed Central  Google Scholar 

Barbot M, Zilio M, Scaroni C (2020) Cushing’s syndrome: overview of clinical presentation, diagnostic tools and complications. Best Pract Res Clin Endocrinol Metab 34:101380. https://doi.org/10.1016/j.beem.2020.101380

Article  CAS  PubMed  Google Scholar 

Pivonello R, De Martino MC, De Leo M et al (2017) Cushing’s disease: the burden of illness. Endocrine 56:10–18. https://doi.org/10.1007/s12020-016-0984-8

Article  CAS  PubMed  Google Scholar 

Giordano R, Picu A, Marinazzo E et al (2011) Metabolic and cardiovascular outcomes in patients with cushing’s syndrome of different aetiologies during active disease and 1 year after remission. Clin Endocrinol (Oxf) 75:354–360. https://doi.org/10.1111/j.1365-2265.2011.04055.x

Article  CAS  PubMed  Google Scholar 

Morbach C, Detomas M, Sahiti F et al (2024) Cardiovascular status in endogenous cortisol excess: the prospective CV-CORT-EX study. Eur J Endocrinol 191:604–613. https://doi.org/10.1093/ejendo/lvae145

Article  PubMed  Google Scholar 

Valassi E (2022) Clinical presentation and etiology of cushing’s syndrome: data from ERCUSYN. J Neuroendocrinol 34:e13114. https://doi.org/10.1111/jne.13114

Article  CAS  PubMed  Google Scholar 

Ferraù F, Korbonits M (2018) Metabolic syndrome in cushing’s syndrome patients. Front Horm Res 49:85–103. https://doi.org/10.1159/000486002

Article  CAS  PubMed  Google Scholar 

Geer EB, Shen W, Strohmayer E et al (2012) Body composition and cardiovascular risk markers after remission of cushing’s disease: a prospective study using whole-body MRI. J Clin Endocrinol Metab 97:1702–1711. https://doi.org/10.1210/jc.2011-3123

Article  CAS  PubMed  PubMed Central  Google Scholar 

Coulden A, Hamblin R, Wass J, Karavitaki N (2022) Cardiovascular health and mortality in cushing’s disease. Pituitary 25:750–753. https://doi.org/10.1007/s11102-022-01258-4

Article  PubMed  PubMed Central  Google Scholar 

Clayton RN, Jones PW, Reulen RC et al (2016) Mortality in patients with cushing’s disease more than 10 years after remission: a multicentre, multinational, retrospective cohort study. Lancet Diabetes Endocrinol 4:569–576. https://doi.org/10.1016/S2213-8587(16)30005-5

Article  PubMed  Google Scholar 

Colao A, Pivonello R, Spiezia S et al (1999) Persistence of increased cardiovascular risk in patients with cushing’s disease after five years of successful cure. J Clin Endocrinol Metab 84:2664–2672. https://doi.org/10.1210/jcem.84.8.5896

Article  CAS  PubMed  Google Scholar 

Barahona M-J, Sucunza N, Resmini E et al (2009) Persistent body fat mass and inflammatory marker increases after long-term cure of cushing’s syndrome. J Clin Endocrinol Metab 94:3365–3371. https://doi.org/10.1210/jc.2009-0766

Article  CAS  PubMed  Google Scholar 

Lupoli R, Ambrosino P, Tortora A et al (2017) Markers of atherosclerosis in patients with cushing’s syndrome: a meta-analysis of literature studies. Ann Med 49:206–216. https://doi.org/10.1080/07853890.2016.1252055

Article  PubMed  Google Scholar 

Rudman Y, Fleseriu M, Dery L et al (2024) Endogenous cushing’s syndrome and cancer risk. Eur J Endocrinol 191:223–231. https://doi.org/10.1093/ejendo/lvae098

Article  PubMed  Google Scholar 

Dery L, Stern J, Shimon I et al (2024) Impact of etiology, sex, diabetes mellitus and remission status on erythrocytic profile in patients with cushing’s syndrome: a large population database study. Pituitary 27:389–402. https://doi.org/10.1007/s11102-024-01399-8

Article  PubMed  Google Scholar 

Garvey WT, Mechanick JI, Brett EM et al (2016) American association of clinical endocrinologists and American college of endocrinology comprehensive clinical practice guidelines for medical care of patients with obesity. Endocr Pract Off J Am Coll Endocrinol Am Assoc Clin Endocrinol 22 Suppl 31–203. https://doi.org/10.4158/EP161365.GL

Kang T, Gridley A, Richardson WS (2015) Long-term outcomes of laparoscopic adrenalectomy for adrenal masses. J Laparoendosc Adv Surg Tech A 25:182–186. https://doi.org/10.1089/lap.2014.0430

Article  PubMed  Google Scholar 

de Fatima Silva F, Komino ACM, Andreotti S et al (2022) Dexamethasone-Induced adipose tissue redistribution and metabolic changes: is gene expression the main factor?? An animal model of chronic hypercortisolism. Biomedicines 10:2328. https://doi.org/10.3390/biomedicines10092328

Article  CAS  PubMed  PubMed Central  Google Scholar 

Bertagna X, Guignat L, Groussin L, Bertherat J (2009) Cushing’s disease. Best Pract Res Clin Endocrinol Metab 23:607–623. https://doi.org/10.1016/j.beem.2009.06.001

Article  CAS  PubMed  Google Scholar 

Othonos N, Pofi R, Arvaniti A et al (2023) 11β-HSD1 Inhibition in men mitigates prednisolone-induced adverse effects in a proof-of-concept randomised double-blind placebo-controlled trial. Nat Commun 14:1025. https://doi.org/10.1038/s41467-023-36541-w

Article  CAS  PubMed  PubMed Central  Google Scholar 

Chen C, Ye Y, Zhang Y et al (2019) Weight change across adulthood in relation to all cause and cause specific mortality: prospective cohort study. BMJ 367:l5584. https://doi.org/10.1136/bmj.l5584

Article  PubMed  PubMed Central  Google Scholar 

Palmer AK, Jensen MD (2022) Metabolic changes in aging humans: current evidence and therapeutic strategies. J Clin Invest 132:e158451. https://doi.org/10.1172/JCI158451

Article  PubMed  PubMed Central  Google Scholar 

Lambert JK, Goldberg L, Fayngold S et al (2013) Predictors of mortality and long-term outcomes in treated cushing’s disease: a study of 346 patients. J Clin Endocrinol Metab 98:1022–1030. https://doi.org/10.1210/jc.2012-2893

Article  CAS  PubMed  PubMed Central